89bio presents additional analysis of phase 1b/2a nash study at the annual endo 2021 conference

New analysis shows bio89-100 meaningfully reduces liver fat volume and liver volume in patients with nash new analysis shows bio89-100 meaningfully reduces liver fat volume and liver volume in patients with nash

ETNB Ratings Summary

ETNB Quant Ranking